Search - tctmd.com

Displaying 1 - 20 of 74

Sort: Relevancy | Date

LAAO May Be an Option for Anticoagulated AF Patients With Breakthrough Stroke

News Daily News

LAAO May Be an Option for Anticoagulated AF Patients With Breakthrough Stroke

September 30, 2025

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

News Daily News

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

July 21, 2025

Don’t Forget to Floss! Better Oral Hygiene May Help Stave Off Stroke

News Conference News ESOC 2025

Don’t Forget to Floss! Better Oral Hygiene May Help Stave Off Stroke

May 23, 2025

DOACs Reduce Stroke, Increase Bleeding in ICH Survivors With AF

News Daily News

DOACs Reduce Stroke, Increase Bleeding in ICH Survivors With AF

March 06, 2025

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

News Conference News AHA 2024

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

November 16, 2024

Asundexian for AF? More Details on the Sinking of OCEANIC-AF

News Conference News ESC 2024

Asundexian for AF? More Details on the Sinking of OCEANIC-AF

September 02, 2024

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

August 19, 2024

TEMPO-2: Tenecteplase No Help in Mild Stroke With Proven Occlusion

News Conference News ESOC 2024

TEMPO-2: Tenecteplase No Help in Mild Stroke With Proven Occlusion

May 23, 2024

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

News Conference News ESOC 2024

Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet

May 16, 2024

News Daily News

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

February 13, 2024

DAPT Works When Started Up to 3 Days After Mild Stroke, TIA

News Daily News

DAPT Works When Started Up to 3 Days After Mild Stroke, TIA

January 04, 2024

Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs

News Daily News

Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs

Michael O'Riordan

November 27, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

November 12, 2023

With Focus on Stroke, Low-Dose Aspirin Still No Good for Primary Prevention

News Daily News

With Focus on Stroke, Low-Dose Aspirin Still No Good for Primary Prevention

July 26, 2023

ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy

News Conference News ESOC 2023

ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy

May 25, 2023

Cilostazol, Isosorbide Mononitrate May Help After Lacunar Stroke: LACI-2

News Conference News ISC 2023

Cilostazol, Isosorbide Mononitrate May Help After Lacunar Stroke: LACI-2

February 10, 2023

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

February 02, 2023

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2

News Daily News

Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2

Yael L. Maxwell

November 03, 2022

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.